NeuroOne Medical Technologies (NASDAQ:NMTC – Get Free Report) and Innovative Eyewear (NASDAQ:LUCY – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk.
Earnings & Valuation
This table compares NeuroOne Medical Technologies and Innovative Eyewear”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| NeuroOne Medical Technologies | $12.10 million | 0.85 | -$3.61 million | ($0.95) | -1.19 |
| Innovative Eyewear | $3.41 million | 2.36 | -$7.59 million | ($1.29) | -0.72 |
Profitability
This table compares NeuroOne Medical Technologies and Innovative Eyewear’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| NeuroOne Medical Technologies | -71.50% | -128.12% | -86.34% |
| Innovative Eyewear | -225.26% | -88.90% | -80.34% |
Analyst Ratings
This is a summary of current recommendations and price targets for NeuroOne Medical Technologies and Innovative Eyewear, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| NeuroOne Medical Technologies | 1 | 1 | 3 | 0 | 2.40 |
| Innovative Eyewear | 1 | 1 | 0 | 0 | 1.50 |
NeuroOne Medical Technologies currently has a consensus target price of $7.33, suggesting a potential upside of 548.97%. Given NeuroOne Medical Technologies’ stronger consensus rating and higher possible upside, equities analysts clearly believe NeuroOne Medical Technologies is more favorable than Innovative Eyewear.
Institutional and Insider Ownership
16.1% of NeuroOne Medical Technologies shares are held by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are held by institutional investors. 11.8% of NeuroOne Medical Technologies shares are held by company insiders. Comparatively, 1.7% of Innovative Eyewear shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Risk and Volatility
NeuroOne Medical Technologies has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500. Comparatively, Innovative Eyewear has a beta of 2.74, meaning that its stock price is 174% more volatile than the S&P 500.
Summary
NeuroOne Medical Technologies beats Innovative Eyewear on 9 of the 14 factors compared between the two stocks.
About NeuroOne Medical Technologies
NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.
About Innovative Eyewear
Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.
Receive News & Ratings for NeuroOne Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeuroOne Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
